Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Targeted cancer therapies often cause serious skin problems that need careful management.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Myc changes chromatin in stem cells, causing them to leave their niche.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Alopecia areata treatment varies, with no optimal method established yet.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Some common medications can harm male fertility, but many effects can be reversed.